Your browser doesn't support javascript.
loading
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.
Clark, Jeffrey W; Camidge, D Ross; Kwak, Eunice L; Maki, Robert G; Shapiro, Geoffrey I; Chen, Isan; Tan, Weiwei; Randolph, Sophia; Christensen, James G; Ozeck, Mark; Tang, Yiyun; Wilner, Keith D; Salgia, Ravi.
Afiliación
  • Clark JW; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Camidge DR; Division of Medical Oncology, University of Colorado Comprehensive Cancer Center, Aurora, CO 80045, USA.
  • Kwak EL; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Maki RG; Don Monti Division of Medical Oncology & Hematology, Northwell Cancer Institute & Cold Spring Harbor Laboratory, Lake Success, NY 11724, USA.
  • Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Chen I; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Tan W; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Randolph S; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Christensen JG; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Ozeck M; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Tang Y; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Wilner KD; Oncology Clinical Development, Pfizer Oncology, La Jolla, CA 92121, USA.
  • Salgia R; Department of Medical Oncology & Therapeutics Research, The City of Hope, Duarte, CA 91010, USA.
Future Oncol ; 16(1): 4289-4301, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31778074
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Proteínas Proto-Oncogénicas / Proteínas Proto-Oncogénicas c-met / Crizotinib / Quinasa de Linfoma Anaplásico / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Proteínas Proto-Oncogénicas / Proteínas Proto-Oncogénicas c-met / Crizotinib / Quinasa de Linfoma Anaplásico / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Future Oncol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos